Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy

Am J Gastroenterol. 2000 Aug;95(8):1861-2. doi: 10.1111/j.1572-0241.2000.02240.x.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Budesonide / therapeutic use
  • Cholagogues and Choleretics / therapeutic use
  • Cholangitis, Sclerosing / drug therapy*
  • Drug Therapy, Combination
  • Gastroenterology / trends*
  • Humans
  • Prednisone / therapeutic use
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Cholagogues and Choleretics
  • Budesonide
  • Ursodeoxycholic Acid
  • Prednisone